Slagle Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.08M Buy
16,066
+1,022
+7% +$238K 1.22% 31
2026
Q1
$3.68M Buy
15,044
+149
+1% +$34.7K 1.21% 32
2025
Q4
$3.08M Sell
14,895
-91
-0.6% -$18K 1.08% 40
2025
Q3
$2.78M Buy
14,986
+393
+3% +$67.3K 1.02% 44
2025
Q2
$2.23M Buy
14,593
+479
+3% +$73.6K 0.9% 50
2025
Q1
$2.34M Buy
14,114
+86
+0.6% +$13.5K 1.04% 36
2024
Q4
$2.03M Buy
14,028
+644
+5% +$99.8K 0.91% 44
2024
Q3
$2.17M Buy
13,384
+599
+5% +$95.4K 0.96% 44
2024
Q2
$1.87M Buy
12,785
+698
+6% +$104K 0.96% 43
2024
Q1
$1.91M Sell
12,087
-13,839
-53% -$2.2M 1.04% 43
2023
Q4
$2.05M Buy
25,926
+13,091
+102% +$2.01M 1.17% 39
2023
Q3
$2M Buy
12,835
+657
+5% +$108K 1.23% 30
2023
Q2
$2.02M Buy
+12,178
New +$1.97M 1.25% 29

Other funds holding JNJ

Slagle Financial's JNJ Position: Q2 2026 in Review

Slagle Financial increased its Johnson & Johnson (JNJ) stake by 6.8% in Q2 2026, buying an estimated $238K and bringing the position to 16,066 shares worth $4.08M. The position accounts for 1.22% of the portfolio, ranked #31.

Slagle Financial first reported a position in JNJ in Q2 2023 and has held it in 13 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Slagle Financial held 16,066 shares of Johnson & Johnson worth $4.08M as of Q2 2026.
  • Slagle Financial bought 1,022 Johnson & Johnson shares in Q2 2026, an estimated $238K.
  • Johnson & Johnson made up 1.22% of Slagle Financial's portfolio in Q2 2026, its #31 holding.
  • Slagle Financial first reported a position in Johnson & Johnson in Q2 2023 and has held it in 13 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Slagle Financial's 13F filing for Q2 2026, filed 29 Jul 2026.